findmyKOL
Clinical trialNCT00005797CompletedPhase 2Interventional

Bone Marrow Transplant in Treating Patients With Hematologic Cancers

SponsorH. Lee Moffitt Cancer Center and Research InstituteEnrollment125Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell NeoplasmsMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida

    Tampa, Florida, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 1993
Primary completion
31 Jul 2007
Completion
31 Jul 2007
Last update posted
10 Dec 2020
Registered enrollment
125
Registry id
NCT00005797

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.